Literature DB >> 19793379

Routine scrotal ultrasonography during the follow-up of patients with testicular cancer leads to earlier detection of asynchronous tumours and a high rate of organ preservation.

Brigitte Stoehr1, Florian Zangerl, Eberhard Steiner, Nicolai Leonhartsberger, Andreas Fritzer, Georg Bartsch, Hannes Steiner.   

Abstract

OBJECTIVE: To compare outcomes of patients with asynchronous tumours detected before and after the introduction of scrotal ultrasonography (SUS) during routine follow-up examinations. PATIENTS AND METHODS: Since January 2001 SUS was also used during the follow-up of patients with testicular cancer. A series of 16 consecutive patients with asynchronous bilateral testicular tumours diagnosed while still complying with routine follow up investigations were identified and divided into two groups; group A was diagnosed by palpation only, before 2001, and group B was diagnosed after 2000. The groups were compared statistically for the interval between asynchronous tumours, clinical stage, tumour diameter at the time of diagnosis and rate of testis-sparing surgery.
RESULTS: All tumours in group A were diagnosed by palpation, but only two in group B were palpable at the time of diagnosis. The mean tumour diameter was statistically significantly smaller in group B (1.2 cm) than in group A (2.68 cm); testis-sparing surgery was used in all of group B and only three patients in group A. After organ-sparing surgery all patients had normal testosterone levels. All patients after organ-sparing surgery had adjuvant scrotal radiotherapy because of germ cell tumour, and no patient had a local recurrence.
CONCLUSION: Our data indicate that using SUS for the remaining testicle in routine follow-up visits of patients with testicular cancer leads to the earlier detection of smaller tumours and, consequently, a higher rate of organ preservation. The maintenance of physiological endocrine function might finally result in a better quality of life.
© 2009 THE AUTHORS. JOURNAL COMPILATION © 2009 BJU INTERNATIONAL.

Entities:  

Mesh:

Year:  2009        PMID: 19793379     DOI: 10.1111/j.1464-410X.2009.08906.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  7 in total

Review 1.  [Organ-sparing therapy for testicular cancer].

Authors:  C Breunig; M Schrader; A J Schrader; F Zengerling
Journal:  Urologe A       Date:  2014-09       Impact factor: 0.639

Review 2.  Testis-preserving strategies in testicular germ cell tumors and germ cell neoplasia in situ.

Authors:  Pia Paffenholz; David Pfister; Axel Heidenreich
Journal:  Transl Androl Urol       Date:  2020-01

Review 3.  Organ-sparing approaches for testicular masses.

Authors:  Alvaro Zuniga; Nathan Lawrentschuk; Michael A S Jewett
Journal:  Nat Rev Urol       Date:  2010-08       Impact factor: 14.432

4.  Outcomes of organ-sparing surgery for adult testicular tumors: A systematic review of the literature.

Authors:  Jesse Ory; Udi Blankstein; Daniel C Gonzalez; Aditya A Sathe; Joshua T White; Carlos Delgado; John Reynolds; Keith Jarvi; Ranjith Ramasamy
Journal:  BJUI Compass       Date:  2021-02-23

Review 5.  Contemporary diagnostic work-up of testicular germ cell tumours.

Authors:  Klaus-Peter Dieckmann; Ulrich Frey; Guntram Lock
Journal:  Nat Rev Urol       Date:  2013-11-12       Impact factor: 14.432

6.  Organ-sparing surgery is the treatment of choice in benign testicular tumors.

Authors:  Nicolai Leonhartsberger; Renate Pichler; Brigitte Stoehr; Wolfgang Horninger; Hannes Steiner
Journal:  World J Urol       Date:  2013-10-04       Impact factor: 4.226

Review 7.  Applications of Focused Ultrasound in the Treatment of Genitourinary Cancers.

Authors:  John Panzone; Timothy Byler; Gennady Bratslavsky; Hanan Goldberg
Journal:  Cancers (Basel)       Date:  2022-03-17       Impact factor: 6.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.